| Literature DB >> 27527500 |
Ryan L Brunsing1, Natalie M Schenker-Ahmed1, Nathan S White1, J Kellogg Parsons2, Christopher Kane2, Joshua Kuperman1, Hauke Bartsch1, Andrew Karim Kader2, Rebecca Rakow-Penner1, Tyler M Seibert3, Daniel Margolis4, Steven S Raman4, Carrie R McDonald5, Nikdokht Farid1, Santosh Kesari6, Donna Hansel7, Ahmed Shabaik7, Anders M Dale1,8, David S Karow1.
Abstract
Restriction spectrum imaging (RSI) is a novel diffusion-weighted MRI technique that uses the mathematically distinct behavior of water diffusion in separable microscopic tissue compartments to highlight key aspects of the tissue microarchitecture with high conspicuity. RSI can be acquired in less than 5 min on modern scanners using a surface coil. Multiple field gradients and high b-values in combination with postprocessing techniques allow the simultaneous resolution of length-scale and geometric information, as well as compartmental and nuclear volume fraction filtering. RSI also uses a distortion correction technique and can thus be fused to high resolution T2-weighted images for detailed localization, which improves delineation of disease extension into critical anatomic structures. In this review, we discuss the acquisition, postprocessing, and interpretation of RSI for prostate MRI. We also summarize existing data demonstrating the applicability of RSI for prostate cancer detection, in vivo characterization, localization, and targeting. LEVEL OF EVIDENCE: 5 J. Magn. Reson. Imaging 2017;45:323-336.Entities:
Keywords: biomarker; diffusion-weighted imaging; prostate cancer; restriction spectrum imaging
Mesh:
Year: 2016 PMID: 27527500 PMCID: PMC5222783 DOI: 10.1002/jmri.25419
Source DB: PubMed Journal: J Magn Reson Imaging ISSN: 1053-1807 Impact factor: 4.813